137 related articles for article (PubMed ID: 8381807)
21. Presence of human papillomavirus in genital tumors.
Gissmann L; Boshart M; Dürst M; Ikenberg H; Wagner D; zur Hausen H
J Invest Dermatol; 1984 Jul; 83(1 Suppl):26s-28s. PubMed ID: 6330218
[TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions.
Sasagawa T; Yamazaki H; Dong YZ; Satake S; Tateno M; Inoue M
Int J Cancer; 1998 Feb; 75(4):529-35. PubMed ID: 9466652
[TBL] [Abstract][Full Text] [Related]
23. Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia.
Dillner L; Bekassy Z; Jonsson N; Moreno-Lopez J; Blomberg J
Int J Cancer; 1989 Jan; 43(1):36-40. PubMed ID: 2536005
[TBL] [Abstract][Full Text] [Related]
24. Genital human papillomavirus infections.
Douglas JM; Werness BA
Clin Lab Med; 1989 Sep; 9(3):421-44. PubMed ID: 2551567
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of HPV types 6 and 11 in condylomas and cervical preneoplastic lesions.
Sherman L; Golan Y; Mitrani-Rosenbaum S; Baram A
Virus Res; 1992 Sep; 25(1-2):23-36. PubMed ID: 1329375
[TBL] [Abstract][Full Text] [Related]
26. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M
Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419
[TBL] [Abstract][Full Text] [Related]
27. [Specific serologic studies with a novel authentic HPV antigen (virus-like particles) for HPV-6 antibodies in gynecologic patient samples].
Heim K; Christensen ND; Höpfl R; Wartusch B; Zeimet A; Larcher C; Ruth N; Bergant A; Pirschner G; Dierich MP
Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():25-31. PubMed ID: 8672922
[TBL] [Abstract][Full Text] [Related]
28. HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix.
Torres LM; Cabrera T; Concha A; Oliva MR; Ruiz-Cabello F; Garrido F
Tissue Antigens; 1993 Feb; 41(2):65-71. PubMed ID: 8386400
[TBL] [Abstract][Full Text] [Related]
29. Atypical condylomas of the cervix uteri in Singapore women: a histopathological and immunohistochemical study.
Sutherland IH; Arulkumaran S; Kitchener HC
Aust N Z J Obstet Gynaecol; 1986 May; 26(2):151-4. PubMed ID: 3021107
[TBL] [Abstract][Full Text] [Related]
30. MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study.
Albarran Y Carvajal A; de la Garza A; Cruz Quiroz BJ; Vazquez Zea E; Díaz Estrada I; Mendez Fuentez E; López Contreras M; Andrade-Manzano A; Padilla S; Varela AR; Rosales R
BioDrugs; 2007; 21(1):47-59. PubMed ID: 17263589
[TBL] [Abstract][Full Text] [Related]
31. [Detection of human papillomavirus in condyloma acuminata tissues].
Shao J; Zhou M; Ye Y
Zhonghua Bing Li Xue Za Zhi; 1995 Feb; 24(1):46-8. PubMed ID: 7781118
[TBL] [Abstract][Full Text] [Related]
32. Detection of human papillomavirus types 6/11, 16 and 18 in exfoliated cells from the uterine cervices of Japanese women with and without lesions.
Yokota H; Yoshikawa H; Shiromizu K; Kawana T; Mizuno M
Jpn J Cancer Res; 1990 Sep; 81(9):896-901. PubMed ID: 2172197
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus antibody responses among patients with incident cervical carcinoma.
Wang Z; Konya J; Avall-Lundkvist E; Sapp M; Dillner J; Dillner L
J Med Virol; 1997 Aug; 52(4):436-40. PubMed ID: 9260694
[TBL] [Abstract][Full Text] [Related]
34. Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA.
Krchnák V; Vágner J; Suchánková A; Krcmár M; Ritterová L; Vonka V
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2719-24. PubMed ID: 2174961
[TBL] [Abstract][Full Text] [Related]
35. HPV 16 detection in cervical lesions, physical state of viral DNA and changes in p53 gene.
do Horto dos Santos Oliveira L; Rodrigues Ede V; de Salles Lopes AP; Fernandez Ade P; Cavalcanti SM
Sao Paulo Med J; 2003 Mar; 121(2):67-71. PubMed ID: 12870053
[TBL] [Abstract][Full Text] [Related]
36. Immunocompetent cells in uterine cervical lesions of human papillomavirus origin.
Syrjänen KJ
Gynecol Obstet Invest; 1983; 16(6):327-40. PubMed ID: 6317528
[TBL] [Abstract][Full Text] [Related]
37. [Detection of HPV DNA in the uterine cervical lesions by polymerase chain reaction and in situ hybridization].
Kyo S; Inoue M; Nakazawa A; Ogawa H; Ueda G; Tanizawa O
Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):541-8. PubMed ID: 1647430
[TBL] [Abstract][Full Text] [Related]
38. Predominance of serum antibodies to synthetic peptide stemming from HPV 18 open reading frame E2 in cervical adenocarcinoma.
Lehtinen M; Leminen A; Paavonen J; Lehtovirta P; Hyöty H; Vesterinen E; Dillner J
J Clin Pathol; 1992 Jun; 45(6):494-7. PubMed ID: 1320634
[TBL] [Abstract][Full Text] [Related]
39. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer.
Meschede W; Zumbach K; Braspenning J; Scheffner M; Benitez-Bribiesca L; Luande J; Gissmann L; Pawlita M
J Clin Microbiol; 1998 Feb; 36(2):475-80. PubMed ID: 9466762
[TBL] [Abstract][Full Text] [Related]
40. Detection of HPV-16 DNA in cervical carcinoma by paraffin section in situ hybridization.
Zhang W; Sun Y; Shang M; Jin S; Liang X; Liang K; Wu A; Nan G; Wang X; Zhang W
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):174-5. PubMed ID: 1965917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
